Ionis Pharmaceuticals Newsroom

Ionis Pharmaceuticals Analyst Ratings

Benzinga14:35 ET

The Latest Analyst Ratings For Ionis Pharmaceuticals

BenzingaJul 16 15:01 ET

Ionis Pharmaceuticals Analyst Ratings

BenzingaJul 16 08:53 ET

Ionis Pharmaceuticals' Promising ION582 Leads to Buy Rating Amidst Angelman Syndrome Treatment Potential

TipRanksJul 16 08:27 ET

Morgan Stanley Reaffirms Their Hold Rating on Ionis Pharmaceuticals (IONS)

TipRanksJul 12 08:40 ET

Ionis Pharmaceuticals Analyst Ratings

BenzingaJun 27 08:20 ET

Ionis Pharmaceuticals Analyst Ratings

BenzingaJun 14 05:55 ET

Ionis Pharmaceuticals Analyst Ratings

BenzingaJun 3 05:31 ET

Ionis Pharmaceuticals' Hold Rating Amid Promising HAE Trial Outcomes and Market Considerations

TipRanksMay 31 14:53 ET

Ionis Pharmaceuticals' Donidalorsen Poised for Strong Market Penetration: A Buy Rating Endorsement

TipRanksMay 31 13:49 ET

Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS), Conmed (CNMD) and PTC Therapeutics (PTCT)

TipRanksMay 21 05:45 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Ionis Pharmaceuticals (IONS) and Ultragenyx Pharmaceutical (RARE)

TipRanksMay 20 02:20 ET

Ionis Pharmaceuticals Buy Rating Affirmed on Strong Clinical Data and Robust Pipeline Potential

TipRanksMay 17 07:15 ET

Analysts Are Bullish on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Ionis Pharmaceuticals (IONS)

TipRanksMay 17 05:30 ET

Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), Ionis Pharmaceuticals (IONS) and 89bio (ETNB)

TipRanksMay 16 19:15 ET

Wells Fargo Adjusts Ionis Pharmaceuticals Price Target to $82 From $85, Maintains Overweight Rating

MT NewswiresMay 8 11:14 ET

Wells Fargo Maintains Overweight on Ionis Pharmaceuticals, Lowers Price Target to $82

BenzingaMay 8 10:44 ET

Ionis Pharmaceuticals: Advancing Pipeline and Path to Profitability Justify Buy Rating

TipRanksMay 8 07:26 ET

RBC Capital Sticks to Its Buy Rating for Ionis Pharmaceuticals (IONS)

TipRanksMay 8 06:41 ET

Ionis Pharmaceuticals: A Buy Rating With Promising Drug Developments and Market Potential

TipRanksMay 8 06:15 ET